Cargando…

Qualitative Evaluation of a Complex Intervention to Improve Rheumatic Heart Disease Secondary Prophylaxis

BACKGROUND: Rheumatic heart disease is a high‐burden condition in Australian Aboriginal communities. We evaluated a stepped‐wedge, community, randomized trial at 10 Aboriginal communities from 2013 to 2015. A multifaceted intervention was implemented using quality improvement and chronic care model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Read, Clancy, Mitchell, Alison G., de Dassel, Jessica L., Scrine, Clair, Hendrickx, David, Bailie, Ross S., Johnston, Vanessa, Maguire, Graeme P., Schultz, Rosalie, Carapetis, Jonathan R., Ralph, Anna P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064865/ https://www.ncbi.nlm.nih.gov/pubmed/30018166 http://dx.doi.org/10.1161/JAHA.118.009376

Ejemplares similares

Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High‐Burden Setting: Outcome of a Stepped‐Wedge, Community, Randomized Trial
por: Ralph, Anna P., et al.
Publicado: (2018)

Improving delivery of secondary prophylaxis for rheumatic heart disease in remote Indigenous communities: study protocol for a stepped-wedge randomised trial
por: Ralph, Anna P., et al.
Publicado: (2016)

Adherence to secondary prophylaxis for rheumatic heart disease is underestimated by register data
por: de Dassel, Jessica Langloh, et al.
Publicado: (2017)

How Many Doses Make a Difference? An Analysis of Secondary Prevention of Rheumatic Fever and Rheumatic Heart Disease
por: de Dassel, Jessica Langloh, et al.
Publicado: (2018)

Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach
por: Ralph, Anna P, et al.
Publicado: (2013)

Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
por: Chamberlain-Salaun, Jennifer, et al.
Publicado: (2016)

Rheumatic Heart Disease Prophylaxis in Older Patients: A Register-Based Audit of Adherence to Guidelines
por: Holland, James V, et al.
Publicado: (2018)

Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach
por: He, Vincent Y.F., et al.
Publicado: (2016)

Secondary prophylaxis in rheumatic fever: is it time to change?
por: Taddio, Andrea, et al.
Publicado: (2015)

Adherence to Secondary Prophylaxis Among Patients with Acute  Rheumatic Fever and Rheumatic Heart Disease
por: Woods, John A., et al.
Publicado: (2019)

An evaluation of secondary prophylaxis for rheumatic heart disease in rural Egypt
por: Balbaa, A, et al.
Publicado: (2015)

Adherence to Secondary Prophylaxis for Acute Rheumatic Fever and Rheumatic Heart Disease: A Systematic Review
por: Kevat, Priya M., et al.
Publicado: (2017)

Improving preventive health care in Aboriginal and Torres Strait Islander primary care settings
por: Bailie, Jodie, et al.
Publicado: (2017)

Global research priorities in rheumatic fever and rheumatic heart disease
por: Carapetis, Jonathan R, et al.
Publicado: (2011)

Rheumatic heart disease in The Gambia: clinical and valvular aspects at presentation and evolution under penicillin prophylaxis
por: Jaiteh, Lamin E. S., et al.
Publicado: (2021)

Rheumatic heart disease: infectious disease origin, chronic care approach
por: Katzenellenbogen, Judith M, et al.
Publicado: (2017)

Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost–Utility Analysis
por: Roberts, Kathryn, et al.
Publicado: (2017)

Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever
por: Pelajo, Christina F, et al.
Publicado: (2010)

Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever
por: Kevat, Priya M, et al.
Publicado: (2020)

Secondary penicillin prophylaxis for latent rheumatic heart disease: A naïve realism?
por: Kothari, Shyam S.
Publicado: (2023)

A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies
por: Hand, Robert M, et al.
Publicado: (2019)

Secondary Prophylaxis Among First Nations People With Acute Rheumatic Fever in Australia: An Integrative Review
por: Govender, Kerissa, et al.
Publicado: (2023)

The case for global investment in rheumatic heart-disease control
por: Wyber, Rosemary, et al.
Publicado: (2014)

Rheumatic Fever Follow-Up Study (RhFFUS) protocol: a cohort study investigating the significance of minor echocardiographic abnormalities in Aboriginal Australian and Torres Strait Islander children
por: Rémond, Marc Gerard Wootton, et al.
Publicado: (2012)

Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
por: Zühlke, Liesl J., et al.
Publicado: (2017)

Secondary prophylaxis to control rheumatic heart disease in developing countries: Put into a cage if can’t be killed
por: Barik, Ramachandra
Publicado: (2018)

Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study
por: Oetzel, John G., et al.
Publicado: (2019)

Research priorities for the primordial prevention of acute rheumatic fever and rheumatic heart disease by modifying the social determinants of health
por: Baker, Michael G, et al.
Publicado: (2023)

Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
por: Musoke, Charles, et al.
Publicado: (2013)

Evaluation of a Community-Led Program for Primordial and Primary Prevention of Rheumatic Fever in Remote Northern Australia
por: Ralph, Anna P., et al.
Publicado: (2022)

Therapeutics for rheumatic fever and rheumatic heart disease
por: Ralph, Anna P, et al.
Publicado: (2022)

The Limits of Resilience and the Need for Resistance: Articulating the Role of Music Therapy With Young People Within a Shifting Trauma Paradigm
por: Scrine, Elly
Publicado: (2021)

Compliance to the secondary prophylaxis and awareness of rheumatic heart disease: A cross-sectional study in low-income province of India
por: Prasad, Arun, et al.
Publicado: (2020)

Improving primary prevention of acute rheumatic fever in Australia: consensus primary care priorities identified through an eDelphi process
por: Wyber, Rosemary, et al.
Publicado: (2022)

Contemporary Incidence and Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Australia Using Linked Data: The Case for Policy Change
por: Katzenellenbogen, Judith M., et al.
Publicado: (2020)

Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi‐State Model
por: Cannon, Jeffrey, et al.
Publicado: (2017)

Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
por: Gasse, Brunelle, et al.
Publicado: (2013)

Throat culture positivity rate and antibiotic susceptibility pattern of beta-hemolytic streptococci in children on secondary prophylaxis for rheumatic heart disease
por: Zegeye, Nigus, et al.
Publicado: (2016)

Rheumatic Heart Disease in Pregnancy: New Strategies for an Old Disease?
por: Vaughan, Geraldine, et al.
Publicado: (2021)

A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
por: Kerrigan, Vicki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qd9iigjntd50s8kv3pp66hh37u